Plunkett Research Online: Alexion Pharmaceuticals Inc

ALEXION PHARMACEUTICALS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes therapeutic products for rare diseases. Alexion has five marketed products: Ultomiris (ravulizumab-cwvz), Soliris (eculizumab), Strensiq (asfotase alfa), Kanuma (sebelipase alfa) and Koselugo. .....


ALEXION PHARMACEUTICALS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 203 272-2596
Fax: 203 271-8198
Address: 121 Seaport Blvd.
Boston, MA 02210 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: AstraZeneca plc

Contacts Description

Marc DunovyerCEO
Sean ChristieCFO
See More
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes therapeutic products for rare diseases. Alexion has five marketed products: Ultomiris (ravulizumab-cwvz), Soliris (eculizumab), Strensiq (asfotase alfa), Kanuma (sebelipase alfa) and Koselugo. .....See More See More

$USD, In whole numbers2020201920182017201620152014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture